| Trial Identifier: | D4190C00055 |
| Sponsor: | MedImmune, LLC |
| NCTID:: | NCT02900157 |
| Start Date: | August 2016 |
| Primary Completion Date: | January 2020 |
| Study Completion Date: | January 2020 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English version | |
| Spanish translation | |
| Japanese translation |
| Country | Location |
|---|---|
| Japan | Koto-ku, Japan, 135-8550 |
| Japan | Sapporo-shi, Japan, 003-0804 |
| Japan | Sunto-gun, Japan, 411-8777 |
| United States of America, AZ | Scottsdale, AZ, United States of America, 85258 |
| United States of America, CA | Los Angeles, CA, United States of America, 90025 |
| United States of America, CO | Denver, CO, United States of America, 80218 |
| United States of America, NC | Huntersville, NC, United States of America, 28078 |
| United States of America, TX | San Antonio, TX, United States of America, 78229 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company